Mylan And Biocon’s Semglee Insulin Glargine Approved In US

Product Deemed A Biologic By FDA; Launch May Be Imminent

 
• By Dean Rudge
Lantus
Semglee 'has an identical amino acid sequence to Lantus,' Mylan underlined • Source: Shutterstock

More from Products

More from Generics Bulletin